CDC Alert: Acute Kidney Injury Associated with Synthetic Marijuana Use in Six States CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P.

Slides:



Advertisements
Similar presentations
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research February 4, 2013 Vol.
Advertisements

College Students Who Use Energy Drinks More Than Twice as Likely to Initiate Nonmedical Use of Prescription Stimulants and Analgesics in Subsequent Year.
Prepared by: Amy Lin, MPH. INFANT DEATHS PER 1,000 LIVE BIRTHS, BY STATE: Mississippi Michigan Alabama South Dakota7.11.
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research Sales data from the.
Alliance Discussion with Office of AIDS: November HIV/AIDS Surveillance Surveillance overview HIV Incidence Surveillance Second Surveillance Stakeholder.
From the Monitoring the Future Study Report: The University of Michigan 2012.
1 Alcohol and Substance Abuse Council of Jefferson County, Inc. 167 Polk Street, Suite 320 Watertown, New York Voice: ; Fax: ;
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research April 29, 2013 Vol.
Study Finds Persons Who Fill Buprenorphine Prescriptions Have Higher Rates of Medical Conditions Associated with Pain and Comorbid Psychiatric Disorders.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research March 3, 2014 Vol. 23,
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research The majority of synthetic.
Smallpox Vaccine Safety and Reporting Adverse Events Department of Health and Human Services Centers for Disease Control and Prevention December 2002.
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research January 27, 2014 Vol.
Interobserver Reliability of Acute Kidney Injury Network (AKIN) criteria A single center cohort study Figure 2 The acute kidney injury network (AKIN) criteria.
Copyright restrictions may apply JAMA Pediatrics Journal Club Slides: Intermittent vs Continuous Pulse Oximetry McCulloh R, Koster M, Ralston S, et al.
Clinical Trial Finds That While Buprenorphine-Naloxone Maintenance Reduced Other Opioid Use Among Those Dependent on Prescription Opioids, 91% Were Not.
2015 ANNUAL DATA REPORT V OLUME 2: E ND -S TAGE R ENAL D ISEASE Chapter 2: Healthy People 2020.
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research January 23, 2012 Vol.
CONCLUSIONS New Jersey’s Emergency Department HIV testing sites report higher seroprevalence than non-ED testing sites. Since University Hospital began.
A Spike in Emergency Department Visits Associated With Synthetic Cannabinoid Use – Alaska, 2015 Sarah Shafer Public Health Associate Program Office for.
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
Marijuana Most Commonly Detected Drug Among Male Arrestees Tested by ADAM II in Five U.S. Sites CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o.
The AMA: Reducing Opioid Abuse in America Patrice A. Harris, MD, MA Board Chair American Medical Association September 2016.
Supplementary Data Tables Workforce APPENDIX 5. TRENDWATCH CHARTBOOK 2016 Supplementary Data Tables, Workforce A-38 Table 5.1: Total Number of Active.
World Kidney Day 2016: Kidney Disease & Children
An AKI project for critically ill cancer patients
Pengjun Lu, PhD, MPH;1 Kathy Byrd, MD, MPH;2
FAX CESAR October 17, 2011 Vol. 20, Issue 39
Optimization of pre-ESRD care: The key to improved dialysis outcomes
FAX CESAR February 21, 2011 Vol. 20, Issue 7
2017 Annual Data Report Healthy People 2020.
Volume 81, Issue 5, Pages (March 2012)
Volume 1: Chronic Kidney Disease Chapter 5: Acute Kidney Injury
The Burden of Tobacco Use
Beta blockers in the management of chronic kidney disease
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Objectives Early initiation of continuous renal replacement therapy
2018 Annual Data Report Volume 3: Healthy People 2020
2018 Annual Data Report Volume 1: Chronic Kidney Disease
Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure  Steven Fishbane, Nobuyuki Miyawaki  Kidney International 
Changing Terminology in Renal Research: The Impact of Consensus
Dialysis Facility Ownership and Epoetin Dosing in Hemodialysis Patients: A Dialysis Provider’s Perspective  J. Michael Lazarus, MD, Raymond M. Hakim,
Section 3: Prevention and Treatment of AKI
Volume 62, Issue 3, Pages (March 2015)
Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care  Douglas S.
This Month in AJKD American Journal of Kidney Diseases
2018 Delaware State Epidemiological Profile
The DOPPS Practice Monitor for US Dialysis Care: Update on Trends in Anemia Management 2 Years Into the Bundle  Douglas S. Fuller, MS, Ronald L. Pisoni,
Steven G. Coca, Swathi Singanamala, Chirag R. Parikh 
Tackling Acute Kidney Injury
2018 EAP Utilization & Industry Trends
Etienne Macedo, Ravindra L. Mehta  American Journal of Kidney Diseases 
Volume 70, Issue 12, Pages (December 2006)
Volume 81, Issue 5, Pages (March 2012)
Volume 75, Issue 1, Pages (January 2009)
Volume 68, Pages S4-S10 (August 2005)
Volume 62, Issue 1, Pages (July 2002)
Volume 70, Issue 11, Pages (December 2006)
Kai Singbartl, John A. Kellum  Kidney International 
Volume 62, Issue 4, Pages (October 2002)
Daily nocturnal home hemodialysis
Volume 60, Issue 3, Pages (September 2001)
Consultant Clinical Biochemist
The Burden of Diabetes.
Collecting and using patient and treatment center data to improve care: Adequacy of hemodialysis and end-stage renal disease surveillance1  William M.
Similar risk profiles for post-transplant renal dysfunction and long-term graft failure: UNOS/OPTN database analysis  Nauman Siddiqi, Maureen A. McBride,
In LAC, from 2006 through 2014, fewer people ages 12 and over perceived smoking marijuana once a month harmful (decreased from 40% in to 29%
Assigning Risk Categories to Patients
Optimization of pre-ESRD care: The key to improved dialysis outcomes
Presentation transcript:

CDC Alert: Acute Kidney Injury Associated with Synthetic Marijuana Use in Six States CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research February 18, 2013 Vol. 22, Issue 7  (voice)  (fax)   CESAR FAX may be copied without permission. Please cite CESAR as the source. SOURCE: Adapted by CESAR from Centers for Disease Control and Prevention, “Acute Kidney Injury Associated with Synthetic Cannabinoid Use—Multiple States, 2012,” Morbidity and Mortality Weekly Report (MMWR), 62(6): 93-98, Available online at For more information, contact Michael D. Schwartz at or Sixteen Acute Kidney Injury Cases Associated with Synthetic Marijuana Use, March 16-December 7, 2012 Acute kidney injury following exposure to synthetic cannabinoids has been identified in six states from March to December 2012, according to a recent report from the Centers for Disease Control and Prevention (CDC). Synthetic cannabinoids, also known as synthetic marijuana, K2, and Spice, are psychoactive substances chemically similar to the active ingredient in marijuana that are applied to plant material and smoked (see CESAR FAX, Volume 20, Issue 17). Prompted by hospitalizations in Wyoming for unexplained acute kidney injury after recent use of synthetic marijuana, a collaboration among several state public health officials, poison center toxicologists, forensic laboratory scientists, individual clinicians, and the Arkansas K2 Research Consortium identified 16 cases of synthetic marijuana-associated acute kidney injury in 6 states (Kansas, Oklahoma, Oregon, New York, Rhode Island, and Wyoming (see table below). All of the patients were admitted to the hospital, and five required hemodialysis, a treatment for kidney failure. None of the patients reported preexisting renal dysfunction or use of medication that might have caused renal problems. Earlier this month, doctors in Alabama reported four cases of acute kidney injury after ingestion of synthetic marijuana among previously health young men.* The CDC report suggests that “physicians caring for otherwise healthy adolescents and young adults with unexplained [acute kidney injury] should inquire about [synthetic marijuana] use, and cases of suspected [synthetic marijuana] poisoning should be reported to both the regional poison center and the appropriate state health department” (p. 97). State Number of Cases Ages (median 18.5 yrs) Peak Creatinine (normal= mg/dL) Implicated Product(s) Kansas1267.7Mr. Happy Oklahoma Flame 2.0 Oregon synthetic cannabinoid; Mad Monkey or Clown Loyal; Lava New York Phantom Wicked Dreams; Spice Gold Rhode Island synthetic cannabinoid Wyoming synthetic cannabinoid; blueberry flavored; bubble gum flavored *Bhanushali, G.K., Jain, G., Fatima, H., Leisch, L., Thornley-Brown, D., “AKI Associated with Synthetic Cannabinoids: A Case Series,” Clinical Journal of the American Society of Nephrology, published online before print December Online at Also see press release at synthetic-marijuana-dangerous-for-kidneys